PPT-WHONET and Multidrug resistance
Author : roxanne | Published Date : 2024-02-09
John Stelling MD MPH jstellingwhonetorg Brigham and Womens Hospital Harvard Medical School Boston WHO Collaborating Centre for Surveillance of Antimicrobial Resistance
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "WHONET and Multidrug resistance" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
WHONET and Multidrug resistance: Transcript
John Stelling MD MPH jstellingwhonetorg Brigham and Womens Hospital Harvard Medical School Boston WHO Collaborating Centre for Surveillance of Antimicrobial Resistance Webinar agenda Comments on the WHONET Webinar series. Resistance by possible additional objects in the path of the fault current was not considered Known the short circuit level without fault impedance the fault resistance was calculated with the above mentioned models for linetoline and linetoground f Sperling Kronberg Mack Holocaust Resouce Center. Myra Berkovits and Pat Holland. Bystanders = Spectators = Indifference. The opposite of hate is not love but indifference.. Eli Wiesel. What is a . Victim. AP Physics C. Internal Resistance. All components in a circuit off some type of resistance regardless of how large or small it is. Batteries especially have what is called an . internal resistance. , . What IS Resistance?. On what will resistance depend?. Electrical Resistance. A measure of how easily charge flows through a material. A . Resistor. is a material of significant resistance that has been placed in an electric circuit in order to control current or voltage. P. Stogsdill, MD, FIDSA. Sept 2013. Bad bugs, No drugs. NO ESKAPE. E. nterococcus . faecium. S. taphylococcus . aureus. K. lebsiella. . pneumoniae. . C. lostridium. . difficile. A. cinetobacter. LT . Christina Jamros, DO (Associate. ) . CDR . Ryan Maves, MD (Fellow. ) . CAPT . Mary . Bavaro. , MD (Fellow). Department of Internal . Medicine. Naval . Medical Center, San Diego, CA. Disclosure. I have no relevant financial relationships with any commercial supporters.. meningitis in the United States, 1993-2005. Presenter: . Christopher Vinnard. World Epidemiology Congress 2011. Edinburgh, Scotland. Disclosures. No authors have financial or non-financial conflicts of interests that may be relevant to this presentation. Pérez-Lago L, Lirola M, Navarro Y, Herranz M, Ruiz-Serrano M, Bouza E, et al. Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis. Emerg Infect Dis. 2015;21(11):2098-2100. https://doi.org/10.3201/eid2111.150683. Last Updated: December 28, 2022. Prepared by:. David H. Spach, MD. Brian R. Wood, MD. Subcutaneous . Lenacapavir. Administer as Subcutaneous Injection. Take with or without food. Oral . Lenacapavir. Lenacapavir. Dierberg KL, Dorjee K, Salvo F, Cronin WA, Boddy J, Cirillo D, et al. Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India. Emerg Infect Dis. 2016;22(3):463-468. https://doi.org/10.3201/eid2203.140732. CAPELLA. Lenacapavir. in Multidrug Resistant HIV. CAPELLA Study: Background. Source: Segal-Maurer S, et al. N . Engl. J Med. 2022;386:1793-1803. . Background. Phase 3, randomized, trial with oral and subcutaneous . WHO Collaborating Centre for Surveillance of Antimicrobial Resistance. Module 3 – Data entry. Module 3. Data entry. 3. Manual data entry. You can manually enter data from paper records into WHONET, either with the desktop application or a new web application.. ≥14kg). Ellen White. and Cissy Kityo. on behalf of the ODYSSEY trial team. CHIVA Conference, 3. rd. September 2021. . . . 15. TH . Annual Conference. Baseline characteristics. Camryn Tims, Rajib Biswas, Treiveanna Jenkins, Anup Kundu PhD.. Biology Department, Xavier University; Tulane University Health Sciences Center. In this project, the MDR proteins will be targeted as the major resistant protein in the cancer cell lines. When MRP-1/P-.
Download Document
Here is the link to download the presentation.
"WHONET and Multidrug resistance"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents